Assessment of CYP2D6 activity in very elderly healthy subjects

Fundamental and Clinical Pharmacology

Volumn 10, Issue 2, 1996, Pages 158-159

  Laurent Kenesi, M A ^a   Jacqz Aigrain, E ^b   Lejonc, J L ^a   Jaillon, P ^c   Funck Brentano, C ^c  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

age; CYP2D6; dextromethorphan; elderly; pharmacogenetics

Indexed keywords

CYTOCHROME P450 ISOENZYME; DEXTROMETHORPHAN; DEXTRORPHAN; DRUG METABOLITE;

ADULT; AGE; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HUMAN; LIVER METABOLISM; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOGENETICS; PRIORITY JOURNAL;

EID: 0029938319     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00160.x     Document Type: Article

References (6)

1. Fromm MF, Botsch S, Heinkele G, Evers J, Kroemer HK. Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its phase I and II metabolites. Eur J Clin Pharmacol 1995;48:279-83
2. Funck-Brentano C, Thomas G, Jacqz-Aigrain E et al. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans. J Pharmacol Exp Ther 1992;263:780-6
3. Jackson PR, Tucker GT, Lennard MS, Woods HF. Polymorphic oxidation: pharmacokinetic basis and comparison of experimental indices. Br J Clin Pharmacol 1986;22:541-50
4. Kévorkian JP, Michel C, Hofmann U et al. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan. Clin Pharmacol Ther 1996;(in press)
5. Siegmund W, Hanke W, Zschiesche, Franke G, Biebler KE, Wilke A. N-acetylation and debrisoquine type oxidation polymorphism in Caucasians - with reference to age and sex. Int J Clin Pharmacol Ther Toxicol 1990;28:504-9
6. Vetticaden SJ, Cabana BE, Prasad VK et al. Phenotypic differences in dextromethorphan metabolism. Pharm Res 1989; 6:13-9